October 01, 2014 1:31 PM ET

Health Care Technology

Company Overview of Genophen, Inc.

Executive Profile

Ronald W. Davis Ph.D.

Scientific Advisor, Genophen, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 9 different industries.

See Board Relationships
----

Background

Prof. Ronald W. Davis, also known as Ron, PhD., serves as an Advisor of NexBio Inc. Prof. Davis co-founded ParAllele. He serves as Scientific Advisor of NextBio, Inc. He serves as Scientific Advisor of Genophen, Inc. He serves as Scientific Advisor of Sequenta Inc. He served as Scientific Advisor of CELLective Dx Corporation (formerly CellPoint Diagnostics, Inc.). He is a leader in the development and application of many critical technologies utilized in genomics and ...

Corporate Headquarters

100 Marine Parkway
Redwood City, California 94065

United States

Phone: 650-453-3170
Fax: --

Board Members Memberships

Former Member of Scientific Advisory Board and Director

Education

PhD
California Institute of Technology
BS
Eastern Illinois University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genophen, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.